Stable Coronary Artery Disease Clinical Trial
Official title:
Role of Computed Tomography Coronary Angiography in Optimalization of Percutaneous Coronary Interventions With Stent Implantation.
Verified date | July 2011 |
Source | Institute of Cardiology, Warsaw, Poland |
Contact | n/a |
Is FDA regulated | No |
Health authority | Poland: Ministry of Health |
Study type | Interventional |
The purpose of the study is to determine whether results of the computed tomography coronary angiography may be helpful in planning and performing percutaneous angioplasty in patients with stable angina pectoris.
Status | Completed |
Enrollment | 60 |
Est. completion date | June 2011 |
Est. primary completion date | April 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Stable coronary artery disease - Planned stent implantation into single lesion in native coronary artery - Planned stent diameter: 2.5-4.0 mm Exclusion Criteria: - Women younger than 50 years - Lesion location in left main coronary artery - Atrial fibrilation or other significant arrythmia - Severe chronic obturatory pulmonary disease - Hyperthyroidism - Known allergy to contrast media - Glomerular filtration rate < 30 - Treatment of bifurcation lesion - Stent implantation for in-stent restenosis |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
Poland | Institute of Cardiology | Warsaw |
Lead Sponsor | Collaborator |
---|---|
Institute of Cardiology, Warsaw, Poland | Ministerstwo Nauki i Szkolnictwa Wyzszego, Warszawa, Polska |
Poland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Minimal in stent lumen area as assessed by IVUS | Up to 10 minutes after stent implantation | No | |
Primary | Adequacy of lesion coverage defined as minimal lumen area in reference segments adjacent to stent shoulder. | Up to 10 minutes after stent implantation | No | |
Secondary | Mean stent lumen area | Up to 10 minutes after stent implantation | No | |
Secondary | Mean lumen area and plaque and media area in 10mm segments adjucent to stent edges. | Up to 10 minutes after stent implantation | No | |
Secondary | Qualitative and quantitative assessment of potential complications (tissue prolaps, plaque shift, stent edge dissection and stent malapossition) | Up to 10 minutes after stent implantation | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01243099 -
Prospective Study to Assess DES Re-endothelization in BMS Restenosis and De-novo Lesions
|
N/A | |
Completed |
NCT03312855 -
Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept
|
Phase 2 | |
Completed |
NCT00642811 -
A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders
|
Phase 2 | |
Recruiting |
NCT03089450 -
To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent
|
N/A | |
Completed |
NCT01523392 -
A Pharmacodynamic Study With Ticagrelor in African American Patients
|
Phase 4 | |
Completed |
NCT01209637 -
Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CAD
|
N/A | |
Active, not recruiting |
NCT04434365 -
Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease
|
Phase 1/Phase 2 | |
Completed |
NCT00510588 -
Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
|
N/A | |
Completed |
NCT03384966 -
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
|
Phase 2 | |
Active, not recruiting |
NCT01609465 -
Prognostic Models for People With Stable Coronary Artery Disease
|
N/A | |
Terminated |
NCT00911339 -
Mobilization of Endothelial Progenitor Cells Induced by Atorvastatin in Patients With Stable Coronary Artery Disease Treated With Anti-CD 34 Antibodies Coated Stents
|
Phase 3 | |
Completed |
NCT00984802 -
Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy
|
Phase 2 | |
Completed |
NCT03782688 -
Precise Percutaneous Coronary Intervention Plan (P3) Study
|
||
Completed |
NCT02580851 -
Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention
|
N/A | |
Recruiting |
NCT03313752 -
Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity
|
Phase 3 | |
Completed |
NCT01184300 -
ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation
|
Phase 2/Phase 3 | |
Completed |
NCT01523366 -
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
|
Phase 4 | |
Completed |
NCT01118325 -
An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease
|
Phase 2 | |
Recruiting |
NCT06123728 -
MCG is Clinically Applied to Evaluate Myocardial Ischemic Function in Patients With Stable Coronary Artery Disease
|